The KVax vaccine also increased tumor-infiltrating CD4+ T cells (Fig. 2A), decreased Tregs, and significantly increased a CD4+ effector cell subset (Fig. 3) as well as the ratio of this subset to Tregs (Figs. 3 and  6E). The gene discussed is CD4; the disease is neoplasm.